Loading clinical trials...
Loading clinical trials...
The aim of this study is to determine the efficacy of Theophylline, N-Acetylcysteine and, and Theophylline plus N-acetylcysteine in the prevention of contrast-induced nephropathy. Investigators assume...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Isfahan University of Medical Sciences
NCT05283512 · Contrast-induced Nephropathy, Kidney Injury, and more
NCT06429345 · Contrast-induced Nephropathy
NCT04864847 · Acute Kidney Injury, Contrast-induced Nephropathy
NCT06418542 · Contrast-induced Nephropathy, Acute Kidney Injury
NCT04606056 · Acute Kidney Injury, Contrast-induced Nephropathy
Chamran Hospital
Isfahan, Isfahan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions